Biomarkers of systemic inflammation provide additional prognostic stratification in cancers of unknown primary

Autor: Svenja Harvey, Mark Stares, Julie‐Anne Scott, Tharun Joseph Vattam Thottiyil, Alicia‐Marie Conway, Rachel Haigh, Jackie Brown, Gillian Knowles, Sonali Dasgupta, Kai‐Keen Shiu, Claire Mitchell, Colin Barrie, Natalie Cook, Sally Clive

Publikováno v: Cancer Medicine, Vol 13, Iss 3, Pp n/a-n/a (2024)

Abstract Background Biomarkers of systemic inflammation have been shown to predict outcomes in patients with cancer of unknown primary (CUP). We sought to validate these findings in patients with confirmed CUP (cCUP) and explore their role alongside

Externí odkaz: https://doaj.org/article/c5055b489f1a43e8828eba5e72f48749

COVID‐19 and Oncology: Service transformation during pandemic

Autor: Marco Shiu Tsun Leung, Shangzhe George Lin, Jason Chow, Amer Harky

Publikováno v: Cancer Medicine, Vol 9, Iss 19, Pp 7161-7171 (2020)

Abstract Background The COVID‐19 pandemic has challenged healthcare systems around the world, where resources have refocused on increasing critical bed capacity to prepare for the peak in incidence of COVID‐19. Oncology faces an unprecedented cha

Externí odkaz: https://doaj.org/article/b52168410c1f43d7833f8f6fdf8574b5

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A systematic review of non-standard dosing of oral anticancer therapies

Autor: Faouzi Djebbari, Nicola Stoner, Verna Teresa Lavender

Publikováno v: BMC Cancer, Vol 18, Iss 1, Pp 1-15 (2018)

Abstract Background The use of oral systemic anticancer therapies (SACT) has increased and led to improved cancer survival outcomes, particularly with the introduction of small molecule targeted agents and immunomodulators. Oral targeted SACT are, ho

Externí odkaz: https://doaj.org/article/2ee81b5ec2b743a7b04ceebecd336b67

Initial active surveillance for patients with metastatic renal cell carcinoma: 10 years' experience at a regional cancer Centre

Autor: Mark Stares, Vishwani Chauhan, Jigi Moudgil‐Joshi, Qiu G. Kong, Jahangeer Malik, Aravindhan Sundaramurthy, Tony Elliott, Edward Mains, Steve Leung, Alexander Laird, Stefan N. Symeonides

Publikováno v: Stares, M, Chauhan, V, Moudgil-joshi, J, Kong, Q G, Malik, J, Sundaramurthy, A, Elliott, T, Mains, E, Leung, S, Laird, A & Symeonides, S N 2022, ' Initial active surveillance for patients with metastatic renal cell carcinoma: 10 years' experience at a regional cancer Centre ', Cancer Medicine . https://doi.org/10.1002/cam4.5330, https://doi.org/10.1002/cam4.5330

A subset of patients with metastatic renal cell carcinoma (mRCC) follow an indolent disease course and may benefit from initial active surveillance (AS). However, selecting patients suitable for this approach is challenging. To investigate this we so

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbac32be05310c5c8233ce73406f9c76
https://hdl.handle.net/20.500.11820/0e03d910-e14e-42ea-860b-b57e25a2500c